Clinical Trials Arena July 29, 2024
Clinical trial trends point to studying combination therapies and lifestyle changes using alternate designs in Alzheimer’s research.
As the industry paints an increasingly clearer picture for Alzheimer’s disease pathologies, treatments are becoming more inclusive of non-pharmacological lifestyle changes, while clinical trials are moving towards optimised operations.
Experts deliberated these and other Alzheimer’s disease drug development trends at the 2024 Alzheimer’s Association International Conference (AAIC), being held 28 July – 1 August in Philadelphia, Pennsylvania.
Mechanistically, the field has a better understanding of the distinct Alzheimer’s pathologies—specifically related to amyloid and tau—and has developed multiple effective approaches to address these pathologies, said Dr. Eric McDade, professor of Neurology at Washington University School of Medicine in St. Louis, Missouri, at a discussion...
Today's Sponsors
Today's Sponsor